UFA
BIIB icon

US Financial Advisors’s Biogen BIIB Stock Holding History

US Financial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-104
Closed -$42K – 561
2015
Q2 		$42K Hold
104
– – 0.04% 119
2015
Q1 		$44K Hold
104
– – 0.04% 121
2014
Q4 		$35K Buy
+104
New +$33.6K 0.03% 132

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

US Financial Advisors's BIIB Position: Q3 2015 in Review

US Financial Advisors sold out of Biogen (BIIB) in Q3 2015, closing a stake of 104 shares — an estimated $42K sold.

US Financial Advisors first reported a position in BIIB in Q4 2014 and held it in 3 quarters. The position peaked at $44K in Q1 2015. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • US Financial Advisors reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • US Financial Advisors sold 104 Biogen shares in Q3 2015, an estimated $42K.
  • US Financial Advisors first reported a position in Biogen in Q4 2014 and held it in 3 quarters.
  • US Financial Advisors's Biogen position peaked at $44K in Q1 2015.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on US Financial Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.